Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kurt Miller

Showing results (201-210 of 290) with videos related to

Pageof 29
Sort By:
BJU International|October 12, 2013
Higher rates of upgrading and upstaging in older patients undergoing radical prostatectomy and qualifying for active surveillanceJonas Busch, Ahmed Magheli, Natalia Leva, et al.
Cancer|July 13, 2012
Phase 3, randomized, placebo-controlled study of zibotentan (ZD4054) in patients with castration-resistant prostate cancer metastatic to boneJoel B Nelson, Karim Fizazi, Kurt Miller, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 15, 2010
Systemic immune tuning in renal cell carcinoma: favorable prognostic impact of TGF-β1 mRNA expression in peripheral blood mononuclear cellsAntonia Busse, AnneMarie Asemissen, Anika Nonnenmacher, et al.
World Journal of Urology|December 18, 2015
Efficacy of fourth-line targeted therapy in patients with metastatic renal cell carcinoma: a retrospective analysisBernhard Ralla, Barbara Erber, Irena Goranova, et al.
Clinical Genitourinary Cancer|February 15, 2020
Treatment Patterns and Outcomes in Patients With Metastatic Castration-resistant Prostate Cancer in a Real-world Clinical Practice Setting in the United StatesDaniel J George, Oliver Sartor, Kurt Miller, et al.
BJU International|July 5, 2012
Outcomes after laparoscopic living donor nephrectomy: comparison of two laparoscopic surgeons with different levels of expertiseFrank Friedersdorff, Peter Werthemann, Hannes Cash, et al.
NPJ Digital Medicine|July 21, 2023
The IMPACT framework and implementation for accessible in silico clinical phenotyping in the digital eraAndrew Wen, Huan He, Sunyang Fu, et al.
European Journal of Cancer (Oxford, England : 1990)|January 11, 2011
Immunomodulatory effects of sorafenib on peripheral immune effector cells in metastatic renal cell carcinomaAntonia Busse, Anne Marie Asemissen, Anika Nonnenmacher, et al.
Urologia Internationalis|May 24, 2014
Impact of thoracic epidural analgesia on blood loss in radical retropubic prostatectomyDaniel Baumunk, Christof Maria Strang, Siegfried Kropf, et al.
Aktuelle Urologie|November 18, 2017
[The use of partial nephrectomy in the treatment of patients with pT1/pT2 renal cell carcinoma: a trend analysis from a tertiary referral centre]Bernhard Ralla, Stephanie Buhl, Irena Goranova, et al.
Pageof 29

Showing results (201-210 of 290) with videos related to

Sort By:
Pageof 29
BJU International|October 12, 2013
Higher rates of upgrading and upstaging in older patients undergoing radical prostatectomy and qualifying for active surveillanceJonas Busch, Ahmed Magheli, Natalia Leva, et al.
Cancer|July 13, 2012
Phase 3, randomized, placebo-controlled study of zibotentan (ZD4054) in patients with castration-resistant prostate cancer metastatic to boneJoel B Nelson, Karim Fizazi, Kurt Miller, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 15, 2010
Systemic immune tuning in renal cell carcinoma: favorable prognostic impact of TGF-β1 mRNA expression in peripheral blood mononuclear cellsAntonia Busse, AnneMarie Asemissen, Anika Nonnenmacher, et al.
World Journal of Urology|December 18, 2015
Efficacy of fourth-line targeted therapy in patients with metastatic renal cell carcinoma: a retrospective analysisBernhard Ralla, Barbara Erber, Irena Goranova, et al.
Clinical Genitourinary Cancer|February 15, 2020
Treatment Patterns and Outcomes in Patients With Metastatic Castration-resistant Prostate Cancer in a Real-world Clinical Practice Setting in the United StatesDaniel J George, Oliver Sartor, Kurt Miller, et al.
BJU International|July 5, 2012
Outcomes after laparoscopic living donor nephrectomy: comparison of two laparoscopic surgeons with different levels of expertiseFrank Friedersdorff, Peter Werthemann, Hannes Cash, et al.
NPJ Digital Medicine|July 21, 2023
The IMPACT framework and implementation for accessible in silico clinical phenotyping in the digital eraAndrew Wen, Huan He, Sunyang Fu, et al.
European Journal of Cancer (Oxford, England : 1990)|January 11, 2011
Immunomodulatory effects of sorafenib on peripheral immune effector cells in metastatic renal cell carcinomaAntonia Busse, Anne Marie Asemissen, Anika Nonnenmacher, et al.
Urologia Internationalis|May 24, 2014
Impact of thoracic epidural analgesia on blood loss in radical retropubic prostatectomyDaniel Baumunk, Christof Maria Strang, Siegfried Kropf, et al.
Aktuelle Urologie|November 18, 2017
[The use of partial nephrectomy in the treatment of patients with pT1/pT2 renal cell carcinoma: a trend analysis from a tertiary referral centre]Bernhard Ralla, Stephanie Buhl, Irena Goranova, et al.
Pageof 29